Registry of Lobbyists

Monthly Communication Report

5088-615344

Corporation: GlaxoSmithKline Inc.
Associated registration: 953603-5088-68
Communication date: 2024-09-19
Posted date: 2024-10-15

Designated Public Office Holders who participated in the communication: Joel Denis, Director General
Centre for Vaccine and Therapeutics Readiness, Public Health Agency of Canada (PHAC)

Rodrigo Arancibia, Director
Life Science Industries Directorate, Innovation, Science and Economic Development Canada (ISED)

Greg Orencsak , Deputy Minister
Health Canada (HC)

Eric Costen, Associate Deputy Minister
Office of the Associate Deputy Minister, Health Canada (HC)
 
Subject Matter of the communication: Economic Development,  Health,  Research and Development
 
Responsible Officer who filed this communication report: Sridhar Venkatesh
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: